{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T13:17:16Z","timestamp":1787318236118,"version":"build-2736575974"},"reference-count":5,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2019,5,21]],"date-time":"2019-05-21T00:00:00Z","timestamp":1558396800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,5,21]],"date-time":"2019-05-21T00:00:00Z","timestamp":1558396800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eye"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1038\/s41433-019-0473-4","type":"journal-article","created":{"date-parts":[[2019,5,21]],"date-time":"2019-05-21T06:11:42Z","timestamp":1558419102000},"page":"1670-1672","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Metastatic melanoma and immunotherapy-related uveitis: an incidence in Northern Ireland"],"prefix":"10.1038","volume":"33","author":[{"given":"Michael J.","family":"Dolaghan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bode","family":"Oladipo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carole A.","family":"Cooke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara E.","family":"McAvoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,5,21]]},"reference":[{"key":"473_CR1","doi-asserted-by":"publisher","first-page":"j5174","DOI":"10.1136\/bmj.j5174","volume":"359","author":"C Karimkhani","year":"2017","unstructured":"Karimkhani C, Reddy BY, Dellavalle RP, et al. Novel therapies for unresectable and metastatic melanoma. BMJ. 2017;359:j5174.","journal-title":"BMJ"},{"key":"473_CR2","doi-asserted-by":"publisher","first-page":"299","DOI":"10.2147\/CMAR.S31873","volume":"4","author":"S Andrews","year":"2012","unstructured":"Andrews S, Holden R. Characteristics and management of immune related adverse effects associated with Ipilimumab, a new immunotherapy for metastatic melanoma. Cancer Manag Res. 2012;4:299\u2013307.","journal-title":"Cancer Manag Res"},{"key":"473_CR3","doi-asserted-by":"publisher","DOI":"10.1186\/s12348-016-0082-3","volume":"6","author":"L Hahn","year":"2016","unstructured":"Hahn L, Pepple KL. Bilateral neuroretinitis and anterior uveitis following Ipilimumab treatment for metastatic melanoma. J Ophthalmic Inflamm Infect. 2016;6:14.","journal-title":"J Ophthalmic Inflamm Infect"},{"key":"473_CR4","doi-asserted-by":"publisher","first-page":"e183","DOI":"10.1002\/phar.1839","volume":"36","author":"KS Hanna","year":"2016","unstructured":"Hanna KS. A rare case of pembrolizumab-induced uveitis in a patient with metastatic melanoma. Pharmacotherapy. 2016;36:e183\u20138.","journal-title":"Pharmacotherapy"},{"key":"473_CR5","doi-asserted-by":"publisher","DOI":"10.1186\/s12886-017-0541-0","volume":"17","author":"S Sarny","year":"2017","unstructured":"Sarny S, Neumayer M, Kofler J, El-Shabrawi Y. Ocular toxicity due to Trametinib and Dabrafenib. BMC Ophthalmol. 2017;17:146.","journal-title":"BMC Ophthalmol"}],"container-title":["Eye"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41433-019-0473-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41433-019-0473-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41433-019-0473-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T17:07:26Z","timestamp":1684602446000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41433-019-0473-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,21]]},"references-count":5,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["473"],"URL":"https:\/\/doi.org\/10.1038\/s41433-019-0473-4","relation":{},"ISSN":["0950-222X","1476-5454"],"issn-type":[{"value":"0950-222X","type":"print"},{"value":"1476-5454","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,21]]},"assertion":[{"value":"8 May 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}